Description

This session focuses on the economics and practice of lung cancer screening with an emphasis on the multidisciplinary nature of effective programs. The economics of lung cancer screening with an emphasis on costs, cost savings, and benefits of screening will be highlighted. It will also include a panel discussion composed of experts who have successfully implemented screening programs in diverse sets of practice environments and with varying schema for implementation that will demonstrate that there is no single formula for establishing a successful program. One commonality that will be drawn out is the importance of collaboration and coordination with experts outside of radiology. The session will also look at the important role of government organizations, such as the USPSTF and the CMS, play in defining the future of lung cancer screening in the United States relative to reimbursement issues.  

Subspecialties: GEN, TH
Modalities: CT

Speaker(s):

• William Black, MD
• Ralph Drosten, MD
• Myrna Godoy, MD
• Andrea McKee, MD
• Reginald Munden, MBA,MD, DMD, FACR
• Geoffrey Rubin, MBA, MD, FACR
• Charles White, MD, FACR

Disclosures

• Geoffrey Rubin, MBA, MD, FACR : Consultant: Fovia, Inc., and GE Healthcare; Stock Options: HeartFlow
• Andrea McKee, MD : Honoraria: McKesson
• Reginald Munden, MBA,MD, DMD, FACR : Research Grants(Spouse/Partner): Toshiba Medical Systems